Literature DB >> 3005218

K-26, a novel inhibitor of angiotensin I converting enzyme produced by an actinomycete K-26.

M Yamato, T Koguchi, R Okachi, K Yamada, K Nakayama, H Kase, A Karasawa, K Shuto.   

Abstract

A novel inhibitor of angiotensin I converting enzyme (ACE), designated K-26, was isolated from the broth filtrate of an actiomycete K-26. K-26 is a water soluble, acidic peptide composed of an equal mol of L-isoleucine, L-tyrosine and 1(R)-1-amino-2-(4-hydroxyphenyl)-ethylphosphonic acid. The IC50 of K-26 for ACE inhibition was 6.7 ng/ml when hippuryl-L-histidyl-L-leucine was used as a substrate of ACE. K-26 possesses hypotensive activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005218     DOI: 10.7164/antibiotics.39.44

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  12 in total

1.  Structure-activity relationships of the phosphonate antibiotic dehydrophos.

Authors:  Michael Kuemin; Wilfred A van der Donk
Journal:  Chem Commun (Camb)       Date:  2010-09-27       Impact factor: 6.222

2.  Discovery of the Tyrobetaine Natural Products and Their Biosynthetic Gene Cluster via Metabologenomics.

Authors:  Elizabeth I Parkinson; James H Tryon; Anthony W Goering; Kou-San Ju; Ryan A McClure; Jeremy D Kemball; Sara Zhukovsky; David P Labeda; Regan J Thomson; Neil L Kelleher; William W Metcalf
Journal:  ACS Chem Biol       Date:  2018-03-13       Impact factor: 5.100

Review 3.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

4.  Identification of ACE pharmacophore in the phosphonopeptide metabolite K-26.

Authors:  Ioanna Ntai; Brian O Bachmann
Journal:  Bioorg Med Chem Lett       Date:  2007-12-05       Impact factor: 2.823

Review 5.  Biosynthesis of phosphonic and phosphinic acid natural products.

Authors:  William W Metcalf; Wilfred A van der Donk
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 6.  Recent examples of α-ketoglutarate-dependent mononuclear non-haem iron enzymes in natural product biosyntheses.

Authors:  Shu-Shan Gao; Nathchar Naowarojna; Ronghai Cheng; Xueting Liu; Pinghua Liu
Journal:  Nat Prod Rep       Date:  2018-08-15       Impact factor: 13.423

Review 7.  Genomics-enabled discovery of phosphonate natural products and their biosynthetic pathways.

Authors:  Kou-San Ju; James R Doroghazi; William W Metcalf
Journal:  J Ind Microbiol Biotechnol       Date:  2013-11-24       Impact factor: 3.346

8.  Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes.

Authors:  Glenna J Kramer; Akif Mohd; Sylva L U Schwager; Geoffrey Masuyer; K Ravi Acharya; Edward D Sturrock; Brian O Bachmann
Journal:  ACS Med Chem Lett       Date:  2014-02-04       Impact factor: 4.345

9.  Cyanohydrin phosphonate natural product from Streptomyces regensis.

Authors:  Joel P Cioni; James R Doroghazi; Kou-San Ju; Xiaomin Yu; Bradley S Evans; Jaeheon Lee; William W Metcalf
Journal:  J Nat Prod       Date:  2014-01-17       Impact factor: 4.050

10.  Crystal structure of a peptidyl-dipeptidase K-26-DCP from Actinomycete in complex with its natural inhibitor.

Authors:  Geoffrey Masuyer; Gyles E Cozier; Glenna J Kramer; Brian O Bachmann; K Ravi Acharya
Journal:  FEBS J       Date:  2016-11-06       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.